Patient info Open main menu

Lercanidipine hydrochloride 20 mg Film-coated tablets – patient leaflet, side effects, dosage

Last updated: · Text from the MHRA, as of · About this document

Medicine status: Prescription only (POM) Details

Medicine strength:
20 mg
Contains active substance:

Patient leaflet - Lercanidipine Hydrochloride 20 mg film-coated tablets

1. What Lercanidipine hydrochloride is and what it is used for

Lercanidipine hydrochloride belongs to a group of medicines called calcium channel blockers (dihydropyridine derivatives). Lercanidipine is used to treat high blood pressure also known as hypertension in adults over the age of 18 years (it is not recommended for children under 18 years old).

Lercanidipine hydrochloride is used for the treatment of mild to moderate high blood pressure.

2. What you need to know before you take Lercanidipine hydrochloride

Do not take Lercanidipine hydrochloride if

  • You are allergic to Lercanidipine hydrochloride or any of the other ingredients of this medicine (listed in section 6).
  • You have had allergic reactions to medicinal products closely related to Lercanidipine hydrochloride (such as amlodipine, nicardipine, felodipine, isradipine, nifedipine or lacidipine)
  • You are suffering from certain heart diseases:

    • untreated heart failure
    • obstruction to flow of blood from the heart
    • unstable angina (chest discomfiort occurring at rest or progressively increasing)
    • within one month of heart attack
  • You have severe liver or kidney problems
  • You are taking one of the following medicinal products/food:

    • antifungal medicines (such as ketoconazole or itraconazole),
    • macrolide antibiotics (such as erythromycin or troleandomycin)
    • antivirals (such as ritonavir)
    • are taking another medicinal products called ciclosporin or cyclosporin (used after transplants to prevent organ rejection)
    • with grapefruit or grapefruit juice. You must tell your doctor if you think you are (or might become) pregnant or breast-feeding (see pregnancy, breast-feeding and fertility section) Do not use if you are pregnant, breast-feeding, or you wish to become pregnant (see section Pregnancy and breast-feeding for more information).

Warnings and precautions

Talk to your doctor or pharmacist before taking Lercanidipine hydrochloride if

  • You have certain other heart conditions and do

    not have a pacemaker, or you have pre-existing angina

    • You have problem with your liver or kidney or you are on dialysis.

Children and adolescents

Lercanidipine hydrochloride should not be used for children and adolescents under 18 years. Other medicines and Lercanidipine hydrochloride

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription. Especially if you are taking:

  • beta-blockers e.g. metoprolol, diuretics (water tablets) or ACE-inhibitors (medicines to treat high blood pressure).
  • cimetidine (more than 800 mg per day, a medicine for ulcers, indigestion, or heartburn)
  • digoxin (a medicine to treat a heart problem)
  • midazolam (a medicine that helps you sleep)
  • rifampicin (a medicine to treat tuberculosis)
  • astemizole or terfenadine (medicines for allergies)
  • simvastatin (a medicine for high cholesterol value)
  • fluoxetine (a medicine to treat major depressive disorder)
  • amiodarone or quinidine (medicines to treat a fast heart beat)
  • phenytoin or carbamazepine (medicines for epilepsy). Your doctor will want to monitor your blood pressure more frequently than usual. Lercanidipine hydrochloride with food, drink and alcohol
  • A high fat meal significantly increases blood levels of the medicine (see section 3).
  • Patients should not consume alcohol during treatment with Lercanidipine hydrochloride since it may increase the effect of

    Lercanidipine hydrochloride.

  • Patients should not take grapefruit or grapefruit juice (they can increase its hypotensive effect), see section 2.

Pregnancy, breast-feeding and fertility

If you are pregnant or breast-feeding, think you pregnant or may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

Do not take Lercanidipine hydrochloride if you are pregnant or breast-feeding, you wish to become pregnant or if you are not using any contraceptive method.

Driving and using machines

Caution should be exercised because of the possibility of dizziness, weakness, tiredness and rarely sleepiness. Do not drive or use machines until you know how Lercanidipine hydrochloride affects you.

Lercanidipine Hydrochloride Tablets contain Lactose

Lercanidipine Hydrochloride Tablets contain lactose monohydrate. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.

Lercanidipine Hydrochloride Tablets contains sodium

This medicine contains less than 1 mmol sodium (23 mg) per daily dose of 20 mg, that is to say essentially ‘sodium-free’.

3. How to take Lercanidipine Hydrochloride

Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure. Adults:

The recommended dose is half of one tablet of Lercanidipine hydrochloride 20 mg (corresponding to 10 mg Lercanidipine hydrochloride) daily at the same time each day, preferably in the morning at least 15 minutes before breakfast. Your doctor may advise you to increase the dose to one tablet Lercanidipine hydrochloride 20 mg (corresponding to 20 mg Lercanidipine

Back Page hydrochloride) daily, if needed.

The score line is only there to help you break the tablet if you have difficulty swallowing it whole. The tablet should preferably be swallowed with some water.

Use in children: This medicine should not be used in children under 18 years of age.

Elderly:

No adjustment of the daily dose is required. However, special care should be exercised when starting treatment.

Patients with liver or kidney problems

Special care is needed in starting treatment in these patients and an increase in daily dose to 20 mg should be approached with caution. If you take more Lercanidipine hydrochloride than you should

Do not exceed the prescribed dose.

If you take more than the prescribed dose or in the event of overdose, seek medical advice immediately and, if possible, take your tablets and/or the container with you.

Exceeding the correct dosage may cause blood pressure to become too low, and the heart to beat irregularly or faster. It may also lead to unconsciousness.

If you forget to take Lercanidipine hydrochloride

If you forget to take your tablet simply miss that dose and then go on as before.

Do not take a double dose to make up for the forgotten dose.

If you stop taking Lercanidipine hydrochloride

If you stop taking Lercanidipine hydrochloride your blood pressure may increase again. Please consult your doctor before stopping the treatment. If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them. Some side effects can be serious:

If you experience any of these side effects tell your doctor straight away.

Rare: ( may affect up to 1 in 1,000 people):

  • angina pectoris (e.g; chest tightness due to lack of blood to your heart
  • allergic reactions (symptoms include itching, rash urticaria)
  • fainting.

If you suffer from pre-existing angina pectoris, with the group of medicines to which Lercanidipine hydrochloride belongs, you may experience increased frequency, duration or severity of these attacks. Isolated cases of heart attack may be observed.

Other possible side effects:

Common (may affect up to 1 in 10 people):

  • headache
  • fast heart rate
  • feeling of fast or uneven heart beat (palpitations)
  • sudden reddening of your face
  • neck or upper chest (flushing)
  • ankle swelling

Uncommon (may affect up to 1 in 100 people):

  • Fall in blood pressure
  • Dizziness
  • Heartburn
  • Feeling sick
  • Stomach pain
  • Skin rash
  • Itching
  • Muscle pain (myalgia)
  • Passage of large amounts of urine (polyuria)
  • Feeling weak or tired

Rare (may affect up to 1 in 1,000 people):

  • sleepiness (somnolence)
  • feeling sick (nausea)
  • extraordinary daytime urinary frequency

    (pollakiuria

    • vomiting
    • diarrhoea
    • skin rash with red, raised, itchy bumps Not known (frequency cannot be estimated from the available data):
    • swelling of gums (gingival hypertrophy)
    • changes in liver function (detected by blood tests) (reversible increases in serum levels of hepatic transaminases)
    • cloudy fluid (when performing dialysis through a tube into your abdomen)
    • swelling of your face, lip, tongue or throat which may cause difficulty in breathing or swallowing.

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.

5. How to store Lercanidipine hydrochloride

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on each blister strip and on the outer carton. The expiry date refers to the last day of that month.

Do not store above 25°C

Store in the original carton in order to protect from light.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.

6. Contents of the pack and other information

What Lercanidipine hydrochloride 20 mg contains

The active substance is Lercanidipine hydrochloride. One film-coated tablet contains 20 mg Lercanidipine hydrochloride, which is equivalent to 18.8 mg lercanidipine.

The other ingredients are

Core:

Cellulose microcrystalline (Flocel 101), lactose monohydrate, sodium starch glycolate (type A), povidone K 30, magnesium stearate.

Film-coating:

Hypromellose, macrogol 6000, ferric oxide red (E 172), titanium dioxide (E 171).

What Lercanidipine hydrochloride 20 mg looks like and contents of the pack

Lercanidipine hydrochloride 20 mg are pink, round (diameter 8.5 mm), biconvex, film-coated tablets with score line on one side and plain on the other side.

Lercanidipine hydrochloride 20 mg is available in blister packs of 28 film-coated tablets. Not all pack sizes may be marketed.

Marketing Authorisation Holder and Manufacturer

Torrent Pharma (UK) Ltd.

3rd Floor, Nexus Building,

4 Gatwick Road,

Crawley,

West Sussex,

RH10 9BG,

United Kingdom

This leaflet was last revised in 08/2026.

8109812-7803

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 36687/0013

Last revision stated in the text: August 2026 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Lercanidipine Hydrochloride 20 mg film-coated tablets

Prescription needed? Yes, prescription-only medicine (POM)
Active substance Lercanidipine
Strength 20 mg
Pharmaceutical form Oral tablet
Lercanidipine hydrochloride 20 mg Film-coated Tablets
Pink, round (diameter 8.5 mm) biconvex, film-coated tablets with score line on one side and plain on the other side.
The score line is only to facilitate breaking for ease of swallowing and not to divide into equal doses.
How is it taken Oral
Excipients Lercanidipine Hydrochloride 20 mg Film-coated Tablets, Cellulose, microcrystalline (Flocel 101), Lactose monohydrate, Sodium starch glycolate (type A), Povidone K 30, Magnesium stearate, Hypromellose, Macrogol 6000, Ferric oxide red (E 172), Titanium dioxide (E 171)
Pack sizes 28 tablet
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life Lercanidipine hydrochloride 20 mg Film-coated Tablets
3 years.
Storage Do not store above 25°C
Drug group (ATC)
  1. C Cardiovascular system drugs
    1. C08 Calcium channel blockers
      1. C08C Selective calcium channel blockers with mainly vascular effects
        1. C08CA Dihydropyridine derivative selective calcium channel blockers with mainly vascular effects
          1. C08CA13 lercanidipine
Marketing authorisation PL 36687/0013 (first authorised 14 April 2015)
Marketing authorisation holder Torrent Pharma (UK) Ltd.
Codes GTIN 5060623370275 · BNF 02060200

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.2.0 of 19 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.